Spectinomycin modification. II. Spectinomycin C-3'-modification via diazoketone intermediates

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Drug Discovery

Background:

• Spectinomycin is an antibiotic used to treat bacterial infections.
• Understanding its structure-activity relationships is crucial for developing new analogs.
• Modifications to the spectinomycin molecule can alter its efficacy and spectrum of activity.

Purpose of the Study:

• To develop a novel synthetic route for spectinomycin analogs.
• To explore the reactivity of a newly introduced diazo group on the spectinomycin scaffold.
• To synthesize and characterize C-3'-deoxo-, monohalo-, and dihalospectinomycins.

Main Methods:

• Conversion of the C-3'-carbonyl group of N-protected spectinomycin to a diazo group using tosylhydrazone intermediate.
• Base-mediated transformation of the tosylhydrazone to the corresponding diazo compound.
• Subsequent synthetic modifications of the diazo intermediate to yield deoxo- and halo-spectinomycins.

Main Results:

• Efficient synthesis of spectinomycin diazo compounds was achieved.
• A range of C-3'-deoxo-, monohalo-, and dihalospectinomycin analogs were successfully synthesized.
• These novel analogs exhibited reduced bioactivity compared to parent spectinomycin and other derivatives.

Conclusions:

• The diazo group provides a versatile handle for synthesizing spectinomycin derivatives.
• The reduced activity of the synthesized analogs highlights the importance of hydrogen bonding groups at the C-3' position for spectinomycin's biological activity.
• This study refines the structure-activity relationships for spectinomycin, guiding future drug design efforts.